Endoscopy guided drainage of the bile duct for obstructive jaundice
Not Applicable
- Conditions
- Health Condition 1: C00-D49- Neoplasms
- Registration Number
- CTRI/2021/10/037018
- Lead Sponsor
- SL Raheja Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Diagnosis of pancreatic cancer, distal common bile duct (CBD) cholangiocarcinoma, ampullary cancers , hilar blocks, other metastatic conditions eg LN mets, Lymphoma)
•Biliary obstructive symptoms or signs
•Bilirubin level/ alkaline phosphatase level above normal limits
•Patients deemed as unresectable by CT / MRI / PET
•Patients with failed ERCP or anticipated difficult ERCP
Exclusion Criteria
Biliary strictures caused by confirmed benign tumours
•Neoadjuvant chemotherapy for current malignancy
•Palliative indication due to reasons other than surgical candidate status
•Previous biliary drainage by ERCP/PTC
•Patients for whom endoscopic techniques are contraindicated
•Participation in another investigational trial within 180 days
•Pregnancy
Study & Design
- Study Type
- PMS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method We hypothesize that the stent patency via trans-luminal route is better than that via trans-papillary route. <br/ ><br>The primary aim of the study is to compare the stent patency in patients undergoing EUS guided antegrade procedure and EUS-guided HGS. <br/ ><br> <br/ ><br>Timepoint: 3, 6 months <br/ ><br>
- Secondary Outcome Measures
Name Time Method The secondary aim is to compare the short and long term adverse events of the two proceduresTimepoint: 3, 6 months